Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 13 Spondylitis, Ankylosing 4 Psoriasis 4 Colitis, Ulcerative 3 Uveal Melanoma 1 Spondylarthritis 1 Recurrence 1 Plaque Psoriasis 1 Osteoarthritis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Melanoma 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Joint Diseases 1 Inflammatory Bowel Diseases 1 Inflammation 1 Hidradenitis Suppurativa 1 Healthy 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1 Arthritis, Psoriatic 1 Arthritis 1 Acne Vulgaris 1 Abscess 1

Interventions

Microbial Collagenase 13 xiapex 10 Collagenases 4 Triamcinolone Acetonide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Oxycodone 1 Injections, Intra-Articular 1 Ibuprofen 1 High-Energy Shock Waves 1 Enzymes 1 Arthroplasty, Replacement, Shoulder 1 Arthroplasty, Replacement, Elbow 1 Adalimumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dupuytren Contracture × Adalimumab × Clear all

NCT03180957 2024-06-28

RIDD

University of Oxford

Phase 2 Completed

140 enrolled 29 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon ⚡